Safety, tolerability, pharmacokinetics and pharmacodynamics of HSK31858, a novel oral dipeptidyl peptidase‐1 inhibitor, in healthy volunteers: An integrated phase 1, randomized, double‐blind, placebo‐controlled, single‐ and multiple‐ascending dose st

Authors

Institutions

Publication Details

Journal
British Journal of Clinical Pharmacology
Published
2025-04-02
DOI
https://doi.org/10.1002/bcp.70027
Citations
5
Primary Topic
Cystic Fibrosis Research Advances
Type
article
Field-Weighted Citation Impact
7.59
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Safety, tolerability, pharmacokinetics and pharmacodynamics of HSK31858, a novel oral dipeptidyl peptidase‐1 inhibitor, in healthy volunteers: An integrated phase 1, randomized, double‐blind, placebo‐controlled, single‐ and multiple‐ascending dose st

Yuhao Wang, Meixia Chen, Jie Hou, Hanmo Liu et al.
5 citations
British Journal of Clinical Pharmacology
Cystic Fibrosis Research Advances
7.59
article

Safety, tolerability, pharmacokinetics and pharmacodynamics of HSK31858, a novel oral dipeptidyl peptidase‐1 inhibitor, in healthy volunteers: An integrated phase 1, randomized, double‐blind, placebo‐controlled, single‐ and multiple‐ascending dose st

Yuhao Wang, Meixia Chen, Jie Hou, Hanmo Liu, Nan Wu, Lu Wang, Chao Yu, Mengyue Hu
article en
5 citations

Abstract

No abstract available for this paper.
British Journal of Clinical PharmacologyVol. 91(8)
China National Pharmaceutical Group Corporation (China) (CN)
Good health and well-being
Openalex Percentile: Top 3%
Cystic Fibrosis Research Advances
7.59
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.